CLBT — Cellebrite DI Ltd.

Summary of Cellebrite's Q4 and Full Year 2025 Earnings Call

1. Key Financial Results and Metrics

• Annual Recurring Revenue (ARR): Grew 21% to $481 million, including a contribution of $16.1 million from the acquisition of Corellium. Excluding Corellium, ARR growth was 17%.
• Revenue: Q4 revenue increased 18% to $128.8 million; full-year revenue grew 19% to $475.7 million.
• Adjusted EBITDA: Q4 adjusted EBITDA rose 33% to $38.3 million, with a margin of 29.8%. Full-year adjusted EBITDA was $127.6 million, or 26.8% margin.
• Free Cash Flow: Generated $160 million for the year, representing a 34% margin.
• Employee Count: Increased by 10% to 1,285 employees.

2. Strategic Updates and Business Highlights

• Product Development: Successful conversion of 55% of the installed digital forensics base to the Inseyets platform, exceeding the target of 50%.
• SaaS and Cloud Growth: ARR from SaaS and cloud offerings grew over 50%, now representing 22% of total ARR.
• Acquisitions: Completed the acquisition of Corellium, enhancing capabilities in ARM virtualization technology. Announced the acquisition of SCG Canada, focusing on drone forensics.
• AI Integration: Continued development of AI capabilities to enhance productivity and user experience, with a focus on ethical applications in law enforcement and investigations.

3. Forward Guidance and Outlook

• 2026 Guidance: Expected ARR growth of 18% to 19%, with revenue growth of 19% to 20%. Adjusted EBITDA is projected between $149 million to $155 million, with a margin of 26% to 27%.
• Q1 2026 Expectations: Anticipated ARR growth of 20% to 21%, revenue between $127 million to $129 million, and adjusted EBITDA of $26 million to $28 million.

4. Bad News, Challenges, or Points of Concern

• U.S. Federal Segment: Experienced headwinds in 2025, with flat growth expected to improve but still a concern for the upcoming year.
• Foreign Exchange Impact: The strengthening of the shekel against the U.S. dollar is expected to compress margins by about 2 points.
• Integration Challenges: While the acquisition of Corellium is seen as beneficial, the initial costs associated with integration are expected to weigh on margins in the early part of 2026.

5. Notable Q&A Insights

• Acquisition Strategy: Management expressed confidence in executing the integration of Corellium and SCG Canada, emphasizing that the drone forensics market is expanding rapidly and presents significant growth opportunities.
• Federal Spending Environment: There is optimism about pent-up demand in the U.S. federal sector, particularly with upcoming funding and the anticipated approval for FedRAMP Level 4, which could unlock significant contract opportunities.
• AI Applications: Customers are showing strong interest in AI-driven applications for investigations, with potential monetization opportunities identified for 2026.
• Sales Expansion: A 20% increase in sales personnel is aimed at enhancing coverage in public safety, enterprise, and defense intelligence sectors.

Overall, Cellebrite demonstrated solid financial performance in 2025, with strategic investments and acquisitions positioning the company for growth in 2026, despite facing some headwinds in the federal market and foreign exchange pressures.